168 related articles for article (PubMed ID: 17635378)
1. Aspirin chemoprevention in patients with increased risk for colorectal cancer: a cost-effectiveness analysis.
DuPont AW; Arguedas MR; Wilcox CM
Aliment Pharmacol Ther; 2007 Aug; 26(3):431-41. PubMed ID: 17635378
[TBL] [Abstract][Full Text] [Related]
2. Combination aspirin and/or calcium chemoprevention with colonoscopy in colorectal cancer prevention: cost-effectiveness analyses.
Pence BC; Belasco EJ; Lyford CP
Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):399-405. PubMed ID: 23250933
[TBL] [Abstract][Full Text] [Related]
3. The cost-effectiveness of aspirin versus cyclooxygenase-2-selective inhibitors for colorectal carcinoma chemoprevention in healthy individuals.
Hur C; Simon LS; Gazelle GS
Cancer; 2004 Jul; 101(1):189-97. PubMed ID: 15222006
[TBL] [Abstract][Full Text] [Related]
4. Primary prevention of colorectal cancer with low-dose aspirin in combination with endoscopy: a cost-effectiveness analysis.
Hassan C; Rex DK; Cooper GS; Zullo A; Launois R; Benamouzig R
Gut; 2012 Aug; 61(8):1172-9. PubMed ID: 21997545
[TBL] [Abstract][Full Text] [Related]
5. Chemoprevention of colorectal cancer by aspirin: a cost-effectiveness analysis.
Suleiman S; Rex DK; Sonnenberg A
Gastroenterology; 2002 Jan; 122(1):78-84. PubMed ID: 11781283
[TBL] [Abstract][Full Text] [Related]
6. Surveillance colonoscopy is cost-effective for patients with adenomas who are at high risk of colorectal cancer.
Saini SD; Schoenfeld P; Vijan S
Gastroenterology; 2010 Jun; 138(7):2292-9, 2299.e1. PubMed ID: 20226186
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of early colonoscopy surveillance after cancer resection.
Hassan C; Pickhardt PJ; Zullo A; Di Giulio E; Laghi A; Kim DH; Iafrate F
Dig Liver Dis; 2009 Dec; 41(12):881-5. PubMed ID: 19467938
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
Tsoi KK; Ng SS; Leung MC; Sung JJ
Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
[TBL] [Abstract][Full Text] [Related]
9. Surveillance colonoscopy or chemoprevention with COX-2 inhibitors in average-risk post-polypectomy patients: a decision analysis.
Arguedas MR; Heudebert GR; Wilcox CM
Aliment Pharmacol Ther; 2001 May; 15(5):631-8. PubMed ID: 11328256
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of capsule endoscopy in screening for colorectal cancer.
Hassan C; Zullo A; Winn S; Morini S
Endoscopy; 2008 May; 40(5):414-21. PubMed ID: 18302080
[TBL] [Abstract][Full Text] [Related]
11. Summaries for patients. Is aspirin a cost-effective addition to colorectal cancer screening?
Ann Intern Med; 2001 Nov; 135(9):1. PubMed ID: 11759636
[No Abstract] [Full Text] [Related]
12. Screening of colorectal cancer.
Winawer SJ
Surg Oncol Clin N Am; 2005 Oct; 14(4):699-722. PubMed ID: 16226687
[TBL] [Abstract][Full Text] [Related]
13. An economic analysis of aspirin desensitization in aspirin-exacerbated respiratory disease.
Shaker M; Lobb A; Jenkins P; O'Rourke D; Takemoto SK; Sheth S; Burroughs T; Dykewicz MS
J Allergy Clin Immunol; 2008 Jan; 121(1):81-7. PubMed ID: 17716716
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness analysis between primary and secondary preventive strategies for gastric cancer.
Lee YC; Lin JT; Wu HM; Liu TY; Yen MF; Chiu HM; Wang HP; Wu MS; Hsiu-Hsi Chen T
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):875-85. PubMed ID: 17507609
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of early one-year colonoscopy surveillance after polypectomy.
Hassan C; Pickhardt PJ; Di Giulio E; Kim DH; Zullo A; Morini S
Dis Colon Rectum; 2009 May; 52(5):964-71; discussion 971. PubMed ID: 19502863
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of proton pump inhibitor cotherapy in patients taking long-term, low-dose aspirin for secondary cardiovascular prevention.
Saini SD; Schoenfeld P; Fendrick AM; Scheiman J
Arch Intern Med; 2008 Aug; 168(15):1684-90; discussion 1691. PubMed ID: 18695083
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of aspirin treatment in the primary prevention of cardiovascular disease events in subgroups based on age, gender, and varying cardiovascular risk.
Greving JP; Buskens E; Koffijberg H; Algra A
Circulation; 2008 Jun; 117(22):2875-83. PubMed ID: 18506010
[TBL] [Abstract][Full Text] [Related]
18. Aspirin as an adjunct to screening for prevention of sporadic colorectal cancer. A cost-effectiveness analysis.
Ladabaum U; Chopra CL; Huang G; Scheiman JM; Chernew ME; Fendrick AM
Ann Intern Med; 2001 Nov; 135(9):769-81. PubMed ID: 11694102
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of prostate cancer chemoprevention: a quality of life-years analysis.
Svatek RS; Lee JJ; Roehrborn CG; Lippman SM; Lotan Y
Cancer; 2008 Mar; 112(5):1058-65. PubMed ID: 18186497
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of breast cancer risk assessment techniques: a cost-effectiveness analysis.
Ozanne EM; Esserman LJ
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2043-52. PubMed ID: 15598759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
